Systems and methods for determining a minimum effective dose...

Surgery – Respiratory method or device – Means for supplying respiratory gas under positive pressure

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C128S203130

Reexamination Certificate

active

10322443

ABSTRACT:
A system and method for determining a minimum effective dose of an inhaled drug for an individual patient at a given time. The system includes an apparatus to measure a performance measurement of the patient and a data processor capable of communication with the apparatus. The data processor provides a computed minimum effective dose for the individual patient by applying a predetermined rule the performance measurement. The method includes measuring a performance measurement of the patient, communicating the performance measurement to a data processor and computing a minimum effective dose for the patient by applying a predetermined rule to the performance measurement within the data processor.

REFERENCES:
patent: 3991304 (1976-11-01), Hillsman
patent: 5167506 (1992-12-01), Kilis et al.
patent: 5724986 (1998-03-01), Jones, Jr. et al.
patent: 5826570 (1998-10-01), Goodman et al.
patent: 6123068 (2000-09-01), Lloyd et al.
patent: 6348209 (2002-02-01), Placke et al.
patent: 6467477 (2002-10-01), Frank et al.
patent: 6733464 (2004-05-01), Olbrich et al.
Weiner et al. Characteristics of asthma in the elderly. Eur Respir J 1998;12 (3):564-8.
Kamada et al. Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 1996;153:1739-48.
Littlewood JM, Johnson AW, Edwards PA, et al. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988;i:115-6, Wales JKH, Barnes ND, Swift PGF.
Growth retardation in children on steroids in asthma. Lancet 1991;338:1535-6, Wolthers OD, Pederson S.
Controlled study of linear growth in asthmatic children during treatment with inhaled corticosteroids. Pediatrics 1992;89:839-42., Wolthers OD, Pederson S.
Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993;68:673-6, Prifitsk K, Milner AD, Conway E, et al.
Dahl R, Lundback B, Malo J-L. A dose ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-8.
Nikolaizik et al. Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide. Am J Respir Crit Care Med 1996;153:97-101.
Adrenal function in asthma. Arch Dis Child 1990;65:838-40.
Donnelly et al. Effects of budesonide and fluticasone on 24-hour plasma cortisol. Am J Respir Crit Care Med 1997;156:1746-51.
I J M Doull; (downloaded from www.archdischild.com on Sep. 5, 2006); The Effect of Asthma and its Treatment on Growth.
Paltiel Weiner et al. CHEST—The Cardiopulmonary and Critical Care Journal—“Nocturnal Cortisol Secretion in Asthmatic Patients After Inhalation of Flucticasone Propionate”.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Systems and methods for determining a minimum effective dose... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Systems and methods for determining a minimum effective dose..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for determining a minimum effective dose... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3742652

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.